Clinical-stage biotech developing therapies for heritable cardiomyopathies.
Industry: Health Care
First Day Return: +5.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/28/2015 |
Offer Price | $10.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 5.4 |
Deal Size ($mm) | $54 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/28/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $54 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | South San Francisco, CA, United States |
Founded | 2012 |
Employees at IPO | 54 |
Website www.myokardia.com |